You are viewing an archive version of the PSNC website taken on 18th April 2013. This site is not updated, and may be out of date or relate to old NHS structures.
For updated and current information, please visit our new website at www.psnc.org.uk
Skip Navigation
PSNC Home Page
Advanced Search
.

Pharmaceutical Services Negotiating Committee

PSNC Plan and Vision

Writing handsPSNC has agreed its priorities and plan for 2013, setting out the Committee’s work programme and aims for the year in line with its four-year strategy for the development of community pharmacy.

Key priorities for the Committee in 2013 include finalising a multi-year funding settlement based on the Cost of Service Inquiry published in 2011, and developing recognition of the value and potential of community pharmacy service provision in meeting the health needs of the population.

Supporting LPCs to operate as effective local voices for pharmacy in the reformed commissioning environment remains an important priority, but the Committee will also work to support the development of strong and productive relationships with the NHS Commissioning Board at a national level.

PSNC will continue to work with the Department of Health on reimbursement and pricing issues and to ensure that regulations and their administration meet contractor needs. The Committee will look to build alliances within and outside pharmacy to promote the sector’s interests.

The 2013 plan was agreed by Committee members at PSNC’s January 2013 meeting, at which the PSNC subcommittees also agreed their 2013 work plans in line with the overall vision.

Other key workstreams within the plan include:

  • Working to develop models for service delivery in all four domains (medicines optimisation, minor ailments, public health and supporting independent living) ensuring they support the achievement of elements of the health, public health and social care outcomes frameworks;
  • Seeking to ensure the re-commissioning of the New Medicine Service and making progress towards the integration of targeted MURs and the NMS as fully funded Essential services;
  • Ensuring that changes in funding delivery to reward quality and outcomes agreed as part of a funding settlement will be manageable and acceptable to contractors;
  • Ensuring that distribution mechanisms for pharmacy funding incentivise not only quality and service provision but also dispensing;
  • Working to agree reward for procurement activity to ensure protection against income volatility;
  • Working to minimise opportunities for Clinical Commissioning Groups to distort contractor income, and to minimise dispensing at a loss;
  • Supporting LPCs to develop their relationships with local commissioners;
  • Working to ameliorate the problems of supply shortages, limited distribution, the burden associated with securing supplies and adverse procurement terms;
  • Continuing to work with the NHS BSA to improve overall prescription pricing accuracy figures as well as holding it to account on addressing pricing problems at individual contractor level; and
  • Working to agree and implement acceptable prescription pricing transparency systems.

The PSNC 2013 plan in full 

The work plans of PSNC's subcommittees are included in the individual agendas for each subcommittee meeting.


PSNC’s Vision for Community Pharmacy

The 2013 plan was developed with PSNC’s four-year strategy – agreed in 2012 – in mind. This strategy is built around a clear vision for the community pharmacy service in 2016:

Our aims and aspirations for the NHS community pharmacy service:

The community pharmacy service in 2016 will offer support to our communities, helping people to optimise use of medicines to support their health and care for acute and long-term conditions, and providing individualised information, advice and assistance to support the public’s health and healthy living.

  • All pharmacies will provide a cost-effective and high quality range of services to their patients, encouraged by funding arrangements that motivate service provision, reward positive patient outcomes and offer sustainability to contractors.  The value of pharmacy services to patients and the NHS and the wider savings which can be created by the effective use of pharmacy will be evidenced.

  • Pharmacies will be fully integrated into provision of primary care and public health services, and will have a substantial and acknowledged role in the delivery of accessible care at the heart of their community.

  • Pharmacies will be able to deliver a wide range of NHS services to support their customers and patients, and be able to offer them services on equal terms to other primary care providers.

  • Patients will be confident that when they access services from a pharmacy, the pharmacist and other members of the pharmacy team will have the skills and resources necessary to deliver high quality services. Effective communications will ensure seamless integration with other NHS care providers.
  • In some cases arrangements for provision of pharmacy services may include patient registration. All patients will have a free and unfettered choice of pharmacy.

PSNC confirmed via a contractor survey that this aspiration for community pharmacy is supported by the majority of the sector and the Committee is working towards its vision by developing the community pharmacy service across four key domains – medicines optimisation, minor ailments, public health and supporting independent living.

PSNC also believes that developing community pharmacy as the third pillar of the NHS could help the NHS to manage the financial constraints and increasing demands it faces.

PSNC Chief Executive, Sue Sharpe, outlined her vision for community pharmacy this January in her UCL School of Pharmacy lecture.